These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28220881)

  • 21. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
    Gentile S; Bellantuono C
    J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations.
    Myles N; Newall H; Ward H; Large M
    Aust N Z J Psychiatry; 2013 Nov; 47(11):1002-12. PubMed ID: 23761574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid analgesic exposure during the first trimester of pregnancy and the risk of major congenital malformations in infants: a systematic review and meta-analysis
    Varney B; Brett J; Zoega H; Gillies MB; Powell M; Bateman BT; Shand AW; Pearson SA; Havard A
    Anaesthesia; 2024 Sep; 79(9):967-977. PubMed ID: 38715235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.
    Wogelius P; Nørgaard M; Gislum M; Pedersen L; Munk E; Mortensen PB; Lipworth L; Sørensen HT
    Epidemiology; 2006 Nov; 17(6):701-4. PubMed ID: 17028507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal exposure to SSRIs or SNRIs and the risk of congenital abnormalities in offspring: A systematic review and meta-analysis.
    Huang W; Page RL; Morris T; Ayres S; Ferdinand AO; Sinha S
    PLoS One; 2023; 18(11):e0294996. PubMed ID: 38019759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.
    Bérard A; Iessa N; Chaabane S; Muanda FT; Boukhris T; Zhao JP
    Br J Clin Pharmacol; 2016 Apr; 81(4):589-604. PubMed ID: 26613360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SSRI antidepressants and birth defects.
    Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study.
    Bateman BT; Hernandez-Diaz S; Straub L; Zhu Y; Gray KJ; Desai RJ; Mogun H; Gautam N; Huybrechts KF
    BMJ; 2021 Feb; 372():n102. PubMed ID: 33568363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of selective serotonin reuptake inhibitors in pregnancy.
    Alwan S; Friedman JM
    CNS Drugs; 2009; 23(6):493-509. PubMed ID: 19480468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
    Eke AC; Saccone G; Berghella V
    BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration of antidepressant use during pregnancy and risk of major congenital malformations.
    Ramos E; St-André M; Rey E; Oraichi D; Bérard A
    Br J Psychiatry; 2008 May; 192(5):344-50. PubMed ID: 18450657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD.
    Margulis AV; Abou-Ali A; Strazzeri MM; Ding Y; Kuyateh F; Frimpong EY; Levenson MS; Hammad TA
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):942-51. PubMed ID: 23733623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
    Nordeng H; van Gelder MM; Spigset O; Koren G; Einarson A; Eberhard-Gran M
    J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks associated with selective serotonin reuptake inhibitors in pregnancy.
    Malm H; Klaukka T; Neuvonen PJ
    Obstet Gynecol; 2005 Dec; 106(6):1289-96. PubMed ID: 16319254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective serotonin reuptake inhibitors and risk for major congenital anomalies.
    Malm H; Artama M; Gissler M; Ritvanen A
    Obstet Gynecol; 2011 Jul; 118(1):111-120. PubMed ID: 21646927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.
    Davis RL; Rubanowice D; McPhillips H; Raebel MA; Andrade SE; Smith D; Yood MU; Platt R;
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1086-94. PubMed ID: 17729378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SSRIs and heart defects in neonates.
    Klinger G; Merlob P
    BMJ; 2009 Oct; 339():b4288. PubMed ID: 19846494
    [No Abstract]   [Full Text] [Related]  

  • 39. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis.
    Leshem R; Bar-Oz B; Diav-Citrin O; Gbaly S; Soliman J; Renoux C; Matok I
    Curr Neuropharmacol; 2021; 19(6):896-906. PubMed ID: 33655866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.